- World rank, all time
- #16,664 of 42,892
- Rank in Canada
- #356 of 896
- Research works
- 295 ▲ 69% vs 2013–17
- Citations
- 10k 35.5 per fractional work
- Top-10% rate
- 30.4% record average 16.5%
- Open access
- 33% world 28%
What is Muscular Dystrophy Canada known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #11,368 of 20,462 | 25.4% | 121 |
Each strip is that field’s whole ranked pool, with the notch where Muscular Dystrophy Canada sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 5.2×
- Medicine 3.0×
- Immunology and Microbiology 1.4×
- Neuroscience 1.2×
- Health Professions 1.1×
- Dentistry 0.6×
- Psychology 0.5×
- Nursing 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Arts and Humanities 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Energy 0.1×
- Social Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Computer Science 0.0×
- Decision Sciences 0.0×
- Business, Management and Accounting 0.0×
Which keywords describe research at Muscular Dystrophy Canada?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, Epidemiology, Intraocular Pressure, Antisense Oligonucleotides, Clinical Management and Neuromuscular Junction.
- Autoantibodies
- Management
- Self-Assembly
- Optic Nerve
- Genetic Mutations
- Retinal Ganglion Cells
- Biosensors
- Refractive Error
- Global Prevalence
- Neurodegeneration
- Myopia
- Glaucoma
- Spinal Muscular Atrophy
- RNA-Guided
- Genome Engineering
- Antisense Oligonucleotides
- Skeletal Muscle Atrophy
- Stem Cells
- Epidemiology
- Muscle Regeneration
- Intraocular Pressure
- Clinical Management
- Neuromuscular Junction
- SMN1
- Corneal Biomechanics
- Keratoconus
- Gene Therapy
- Risk Factors
- Inflammation
- Visual Impairment
- Nanoparticles
- DNA nanotechnology
- Ocular Hypertension
- RNA Interference
- siRNA Delivery
- Neuroprotection
- Stem Cell Therapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 37 words, with their numbers
- Epidemiology6▲ 2.9×34 topics
- Stem Cells5▲ 36×4 topics
- Muscle Regeneration4▲ 329×1 topic
- Skeletal Muscle Atrophy4▲ 329×1 topic
- Intraocular Pressure3▲ 79×2 topics
- Antisense Oligonucleotides3▲ 140×2 topics
- Clinical Management3▲ 33×3 topics
- Genome Engineering3▲ 84×1 topic
- Neuromuscular Junction3▲ 129×2 topics
- RNA-Guided3▲ 84×1 topic
- SMN13▲ 238×1 topic
- Spinal Muscular Atrophy3▲ 238×1 topic
- Corneal Biomechanics2▲ 122×1 topic
- Glaucoma2▲ 27×3 topics
- Keratoconus2▲ 122×1 topic
- Myopia2▲ 68×2 topics
- Gene Therapy2▲ 20×2 topics
- Neurodegeneration2▲ 12×3 topics
- Risk Factors2▲ 3.5×7 topics
- Global Prevalence2▲ 39×2 topics
- Inflammation2▲ 1.74×15 topics
- Refractive Error2▲ 89×1 topic
- Visual Impairment2▲ 70×1 topic
- Biosensors1▲ 5.3×2 topics
- Nanoparticles1▲ 2.3×3 topics
- Retinal Ganglion Cells1▲ 25×2 topics
- DNA nanotechnology1▲ 22×1 topic
- Genetic Mutations1▲ 6.1×5 topics
- Ocular Hypertension1▲ 52×1 topic
- Optic Nerve1▲ 27×1 topic
- RNA Interference1▲ 31×1 topic
- Self-Assembly1▲ 8.2×1 topic
- siRNA Delivery1▲ 44×1 topic
- Management1▲ 3.0×10 topics
- Neuroprotection1▲ 6.8×5 topics
- Autoantibodies1▲ 9.1×5 topics
- Stem Cell Therapy1▲ 24×2 topics
Which research topics does Muscular Dystrophy Canada publish most on?
By volume in 2022–2025: Muscle Physiology and Disorders, CRISPR and Genetic Engineering, Neurogenetic and Muscular Disorders Research and Corneal surgery and disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Muscle Physiology and Disorders Molecular Biology 4 works
- 2 CRISPR and Genetic Engineering Molecular Biology 3 works
- 3 Neurogenetic and Muscular Disorders Research Genetics 3 works
- 4 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 2 works
- 5 Ophthalmology and Visual Impairment Studies Epidemiology 2 works
- 6 RNA Interference and Gene Delivery Molecular Biology 1 works
- 7 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works
- 8 Glaucoma and retinal disorders Ophthalmology 1 works
- 9 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 1 works
- 10 Tissue Engineering and Regenerative Medicine Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Muscular Dystrophy Canada's research output changed?
Output in 2018–2022 was 69% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toronto
- University of Toronto
- York University
- Hospital for Sick Children
- Toronto Metropolitan University
- University Health Network
- Sunnybrook Health Science Centre
- St. Michael's Hospital
- Princess Margaret Cancer Centre
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.